Arylamidoalkyl-N-hydroxyurea compounds having lipoxygenase inhibitory
申请人:Abbott Laboratories
公开号:US05514702A1
公开(公告)日:1996-05-07
The present invention provides certain (substituted carbocyclic aryl)amidoalkyl- and (substituted heterocyclic aryl)amidoalkyl-N-Hydroxy urea compounds which inhibit lipoxygenase enzyme activity and are thus useful in the treatment of allergic and inflammatory disease states.